AbbVie (ABBV) Pension (2012 - 2015)
AbbVie (ABBV) posted quarterly Pension of $1.9 billion for Q4 2015, down 12.21% YoY from $2.2 billion in Q4 2014, and down 12.21% sequentially from $2.2 billion in Q4 2014.
AbbVie (ABBV) Pension (2012 - 2015) Analysis & Trends
AbbVie has disclosed Pension across 4 years of filings, most recently posting $1.9 billion for Q4 2015.
- In Q4 2015, Pension fell 12.21% year-over-year to $1.9 billion; the TTM figure through Dec 2015 stood at $1.9 billion (down 12.21% YoY), while the FY2015 annual figure was $1.9 billion, down 12.21% from the prior year.
- Pension retreated to $1.9 billion in Q4 2015, from $2.2 billion in the prior quarter.
- Over the last five years, Pension for ABBV reached as high as $2.2 billion in Q4 2014 and fell as low as $979.0 million in Q4 2012.
- The 4-year median for Pension is $1.8 billion (2013), against an average of $1.7 billion.
- Annual changes were most pronounced in 2013 — Pension soared 66.29% — and 2015, when it slipped 12.21%.
- A 4-year view of Pension shows it stood at $979.0 million in 2012, then surged by 66.29% to $1.6 billion in 2013, then surged by 36.36% to $2.2 billion in 2014, then dropped by 12.21% to $1.9 billion in 2015.
- According to Business Quant data, Pension over the past three periods registered $1.9 billion, $2.2 billion, and $1.6 billion for Q4 2015, Q4 2014, and Q4 2013 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 1.95 Bn |
| Dec 31, 2014 | 2.22 Bn |
| Dec 31, 2013 | 1.63 Bn |
| Dec 31, 2012 | 979.00 Mn |